Company Filing History:
Years Active: 2001
Title: The Innovative Contributions of Eric-Paul Pâques
Introduction
Eric-Paul Pâques is a notable inventor based in Marburg, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the area of inflammatory disorders. His work has led to advancements that may improve the quality of life for many patients suffering from chronic conditions.
Latest Patents
Eric-Paul Pâques holds a patent for the "Use of complement inhibitors for the preparation of a pharmaceutical for the prophylaxis and therapy of inflammatory intestinal and skin disorders as well as purpura." This invention focuses on the use of complement inhibitors, specifically C1 inactivator or factors I or H, to create pharmaceuticals aimed at treating chronic inflammatory intestinal disorders, inflammatory skin disorders, and purpura. He has 1 patent to his name.
Career Highlights
Pâques is currently associated with Aventis Behring GmbH, a company known for its commitment to developing innovative therapies. His work at the company has been instrumental in advancing research and development in the pharmaceutical sector.
Collaborations
Throughout his career, Eric-Paul Pâques has collaborated with esteemed colleagues, including Jürgen Römisch and Robert Bartlett. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Eric-Paul Pâques is a distinguished inventor whose work in pharmaceuticals has the potential to make a significant impact on the treatment of inflammatory disorders. His contributions continue to inspire advancements in medical science and improve patient care.